There are many hopeful programs being developed within Telix, strengthening its footing. I am cheering for them all. However, two of them are my elephants in the room right now.
1. What if Zircaix gets approved (conservative revenue estimate 500m USD = 750m AUD) - doubling Telix's currently estimated revenue outlook?
2. What if the phase 3 interim readout of ProstACT GLOBAL (TLX 591) stays roughly within the ballpark of prior overall survival at 42 months (e.g. 35 -45 months)?
Wouldn't you expect a doubling in market cap from number 1 and a further doubling from those heights with number 2, let's say within the next 2 years?
Understanding Telix, page-1076
-
- There are more pages in this discussion • 248 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.52 |
Change
0.330(1.72%) |
Mkt cap ! $6.532B | |||
| Open | High | Low | Value | Volume |
| $19.13 | $19.63 | $19.01 | $18.51M | 951.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 22033 | $19.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.58 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| TLX (ASX) Chart |